aTyr Pharmaceuticals (ATYR) - Uzoq muddatli qarzning kapitalga koeffitsiyenti

aTyr Pharmaceuticals - ATYR emitenti grafik logotipi

aTyr Pharma, Inc. (ATYR) sarkoidozga qarshi kurashish uchun tRNA sintetazalarning klinik sinovlarini olg'a siljitmoqda va shu bilan birga o'z portfelini onkologiya yo'nalishida diversifikatsiya qilmoqda. GURU.Markets tomonidan taqdim etilgan uzoq muddatli qarzdorlikning sof aktivlarga nisbati moliyaviy barqarorlikni namoyish etadi, bunda 0.19 qiymati ushbu darajani xarakterlaydi. Fibrotik patologiyalar uchun terapiya taklif etilayotgan davolash usullarining noyobligi tufayli barqaror talabni va uzoq muddatli marjalarni ta'minlaydi.

aTyr Pharma Inc (ATYR): Uzoq muddatli qarzning o'z kapitaliga nisbati 06.06.2024dan 30.10.2026gacha

aTyr Pharma, Inc. (ATYR) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- aksiya narxi va konsensus maqsadli narx:
Kotirovkalar grafigi aTyr Pharma Inc|ATYR - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi ko'rsatkichlari:
Bozor qiymati aTyr Pharma, Inc.|ATYR - Korxona qiymati
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
Bitta aksiya hisobiga balans qiymati aTyr Pharma|ATYR - Kompaniyaning balans qiymati|Balans qiymatiga nisbatan bozor qiymati atyrpharma.com|ATYR - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati aTyr Pharma, Inc.|ATYR - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati atyrpharma.com|ATYR - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati aTyr Pharma, Inc.|ATYR - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi aTyr Pharma|Tezkor likvidlik ko‘rsatkichi atyrpharma.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
ATYR - Kompaniyaning sof foydasi
Kompaniyaning umumiy tahlili:aTyr Pharma Inc - ATYR
aTyr Pharma, Inc. brend mahsuloti

Operatsion modelning samaradorligi qarz yuklamasining barqarorligiga bevosita ta'sir qiladi. Ushbu ko'rsatkich kapitalga nisbatan muddati bir yildan ortiq bo'lgan majburiyatlarning ulushini o'lchaydi. Barqaror AQSh huquqiy bazasi va aTyr Pharma (ATYR) ishlanmalarining gumanitar maqomi defolt risklarini minimallashtiradi. Past moliyaviy leveraj dori vositalarini ishlab chiqish davrida moliyaviy xavfsizlikni ta'minlaydi. Ushbu grafikda uzoq muddatli qarzning kapitalga nisbatidagi koeffitsiyentining tendentsiyasini baholang.

Muhim raqobatchilar

argenx N.V. - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati BNTX|ABVX (Abivax S.A.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ADMA (ADMA Biologics)|Uzoq muddatli qarzning kapitalga nisbati protagonist-inc.com PTGX|IMVT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti KNSA (Kiniksa Pharmaceuticals, Ltd.)|Grifols Group (GRFS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Adaptive Biotechnologies Inc.|CLDX (Celldex Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati auriniapharma.com|Uzoq muddatli qarzning o'z kapitaliga nisbati BCRX (BioCryst Pharmaceuticals)|VERA (Vera Therapeutics Inc) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati DNTH (Dianthus Pharma)|Uzoq muddatli qarzdorlikning kapitalga nisbati Pharvaris Pharma (PHVS)|ABCL - Uzoq muddatli qarzning o'z kapitaliga nisbati|tourmalinebio.com (TRML) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Precigen (PGEN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Pharming Group NV|Uzoq muddatli qarzning o'z kapitaliga nisbati NKTR|Uzoq muddatli qarzning kapitalga nisbati Upstream Pharma|Uzoq muddatli qarzning o'z kapitaliga nisbati Zenas Biopharma Inc (ZBIO)|immunome.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati GOSS (Gossamer Bio)|KalVista Pharma (KALV) - Uzoq muddatli majburiyatlarning kapitalga nisbati|Septerna Corp - Uzoq muddatli qarzning kapitalga nisbati|PVLA - Uzoq muddatli qarzning kapitalga nisbati|SVRA (Savara Inc.) - Uzoq muddatli qarzning o'z kapitaliga nisbati|RIGL: Uzoq muddatli kreditlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati ANAB|Uzoq muddatli majburiyatlarning kapitalga nisbati Astria Therapeutics Inc ATXS|Uzoq muddatli qarzning o'z kapitaliga nisbati enGene Bio (ENGN)|RAPT (rapt.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Aerovate Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti ACRS|KYTX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati TLSA|CABA: Uzoq muddatli qarzning kapitalga nisbati|Ventyx Biosciences, Inc - Uzoq muddatli qarzning kapitalga koeffitsiyenti|THTX (Theratechnologies Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati avalotx.com|Uzoq muddatli qarzning o'z kapitaliga nisbati Eledon Pharmaceuticals, Inc. (ELDN)|AGEN (Agenus, Inc.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Climb Bio, Inc. CLYM|ZURA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Adagene Corp - Uzoq muddatli qarzning kapitalga nisbati|IMA - Uzoq muddatli qarzning kapitalga nisbati|STTK (shattucklabs.com) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Equillium - Uzoq muddatli qarzning kapitalga koeffitsiyenti|CNTB (Connect Biopharma Holdings) - Uzoq muddatli qarzning kapitalga nisbati|Immunic Inc (IMUX) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Atara Biotherapeutics (ATRA)|inflarx.de - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati XFOR (X4 Pharmaceuticals, Inc.)|ACET - Uzoq muddatli qarzning o'z kapitaliga nisbati|CELU: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati INmune Bio Corporation INMB|BRNS: Uzoq muddatli qarzning kapitalga nisbati|kezarlifesciences.com (KZR) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati SABS|AKTX (Akari Therapeutics PLC) - Uzoq muddatli kreditlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati ENLV (Enlivex Therapeutics)|QTTB - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati GeoVax Labs, Inc. GOVX|Uzoq muddatli qarzning kapitalga koeffitsiyenti EDSA|IBIO - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati CARM|XTLB: Uzoq muddatli qarzning kapitalga nisbati|Bolt Biotherapeutics, Inc. - Uzoq muddatli qarzning kapitalga koeffitsiyenti|HCWB (HCW Biologics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati Aptevo|Uzoq muddatli qarzning o'z kapitaliga nisbati AIM ImmunoTech (AIM)|ADTX (aditxt.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati GRI Bio Corp GRI|XRTX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Vyome Holdings Inc - Uzoq muddatli qarzning kapitalga nisbati|REVB - Uzoq muddatli qarzning kapitalga nisbati|INDP (Indaptus Therapeutics, Inc.) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Scinai Immunotherapeutics Ltd - Uzoq muddatli qarzning kapitalga koeffitsiyenti|CALI (CalciMedica Inc) - Uzoq muddatli qarzning kapitalga nisbati|Affimed Therapeutics (AFMD) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Allakos Inc. (ALLK)|Uzoq muddatli qarzning o'z kapitaliga nisbati hookipapharma.com HOOK|Uzoq muddatli qarzning o'z kapitaliga nisbati IGM Biosciences IGMS|ITOS - Uzoq muddatli qarzning o'z kapitaliga nisbati|OCEA: Uzoq muddatli qarzning o'z kapitaliga nisbati|TCBP - Uzoq muddatli qarzning kapitalga nisbati|Third Harmonic Bio (THRD) - Uzoq muddatli qarzning o'z kapitaliga nisbati